Mediclinic International - ALNRF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $417.50
  • Forecasted Upside: 8,870.01 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$4.65
+0 (0.00%)
Get New Mediclinic International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALNRF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALNRF

Analyst Price Target is $417.50
▲ +8,870.01% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Mediclinic International in the last 3 months. The average price target is $417.50, with a high forecast of $460.00 and a low forecast of $375.00. The average price target represents a 8,870.01% upside from the last price of $4.65.

This chart shows the closing price for ALNRF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Mediclinic International. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/13/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/12/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/12/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/10/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/7/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/31/2022BarclaysBoost TargetGBX 385 ➝ GBX 460
5/27/2022UBS GroupBoost TargetGBX 352 ➝ GBX 375
11/15/2021UBS GroupReiterated RatingNeutral
11/1/2021BarclaysReiterated RatingOverweight
(Data available from 12/7/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/11/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/10/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/10/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/9/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/8/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Mediclinic International logo
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
Read More

Today's Range

Now: $4.65
Low: $4.65
High: $4.65

50 Day Range

MA: N/A

52 Week Range

Now: $4.65
Low: $12.29
High: $12.29

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Mediclinic International?

The following Wall Street analysts have issued research reports on Mediclinic International in the last twelve months: Barclays PLC, and UBS Group AG.
View the latest analyst ratings for ALNRF.

What is the current price target for Mediclinic International?

2 Wall Street analysts have set twelve-month price targets for Mediclinic International in the last year. Their average twelve-month price target is $417.50, suggesting a possible upside of 8,870.0%. Barclays PLC has the highest price target set, predicting ALNRF will reach $460.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $375.00 for Mediclinic International in the next year.
View the latest price targets for ALNRF.

What is the current consensus analyst rating for Mediclinic International?

Mediclinic International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ALNRF.

What other companies compete with Mediclinic International?

How do I contact Mediclinic International's investor relations team?

The company's listed phone number is 27 21 809 6500. The official website for Mediclinic International is www.mediclinic.com. Learn More about contacing Mediclinic International investor relations.